Skip to main content

Forefront Analytics, LLC

SEC CIK
0001696802
Latest filing
Aug 12, 2026

Holdings changes from Q3 2025 to Q4 2025

Long positions only; new, added, reduced and sold out are based on share counts. Pick any two quarters this institution filed.

Choose two quarters to compare

New
4
Est. +$3.00M
Added
27
Est. +$21.8M
Reduced
11
Est. −$7.78M
Sold out
4
Est. −$9.20M

Portfolio value went from $103.8M to $113.3M (+$9.44M (+9.1%)); positions from 43 to 43 (0).

All Q4 2025 holdingsAll Q3 2025 holdings

In the shares, value and % of portfolio columns, the top figure is Q4 2025 and the gray one below is Q3 2025. For stocks that split between the two quarters, Q3 2025 shares are converted at the split ratio before comparing.

Holdings of Forefront Analytics, LLC in Q3 2025 and Q4 2025 compared
SecurityActionSharesShare changeValueEst. bought or sold% of portfolioWeight change (pp)
MREOMereo BioPharma Group plcReducedHistory31,76833,180−1,412−4.3%$13.2K$68.4K−$588.39<0.1%0.1%−0.05
ANNXAnnexon, Inc.ReducedHistory13,22627,027−13,801−51.1%$66.4K$82.4K−$69.3K0.1%0.1%−0.02
GERNGeron CorpReducedHistory51,32052,258−938−1.8%$67.7K$71.6K−$1.24K0.1%0.1%−0.01
ZURAZura Bio LtdReducedHistory19,57721,518−1,941−9.0%$102.6K$93.2K−$10.2K0.1%0.1%0.00
DHRDanaher CorpReducedHistory9151,313−398−30.3%$209.4K$260.3K−$91.1K0.2%0.3%−0.07
iShares Tr464288661Reduced–4,7404,904−164−3.3%$566.0K$586.0K−$19.6K0.5%0.6%−0.06
Vanguard Morningstar Value ETF922908744Reduced–3,46516,444−12,979−78.9%$661.8K$3.07M−$2.48M0.6%3.0%−2.37
First Tr Exchange-Traded FD33738D101Reduced–18,43518,954−519−2.7%$698.0K$726.0K−$19.7K0.6%0.7%−0.08
WisdomTree Tr97717W562Reduced–17,76017,919−159−0.9%$1.01M$1.00M−$9.05K0.9%1.0%−0.07
Flexshares Tr33939L688Reduced–22,99924,370−1,371−5.6%$4.72M$4.81M−$281.4K4.2%4.6%−0.47
Nushares ETF Tr67092P300Reduced–141,379247,947−106,568−43.0%$6.37M$10.9M−$4.80M5.6%10.5%−4.84

Estimated amounts multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares): new positions use this quarter's value and sold-out positions last quarter's; positions reported only as principal (PRN) cannot be estimated. 13F shows only quarter-end holdings, not when trades happened or at what price.